Government Tightens Regulations on Medicinal Alcohol Content: What You Need to Know

New Regulations on Medicinal Formulations

New Delhi: The central government has decided to revoke the licensing exemption for medicinal products that contain over 12% ethyl alcohol. This change aims to implement stricter regulations, including mandatory licensing and prescription-only sales, to prevent misuse and diversion for intoxication, according to officials.

Certain medicinal items, such as tinctures made from cardamom, ginger, and other aromatic substances, will still be exempt from licensing as per Schedule K of the Drugs Rules, 1945, the ministry clarified.

Some of these formulations can have ethyl alcohol concentrations as high as 80-90% by volume, raising concerns about potential misuse for intoxication.

The ministry noted that it received references from various state governments regarding this issue.

To tackle these concerns, the government has mandated that any formulation containing more than 12% v/v ethyl alcohol in quantities exceeding 30 ml will no longer qualify for the exemption under Schedule K.

These products will now require the necessary licenses under the Drugs and Cosmetics Act, 1940.

Additionally, the amendment reclassifies these products to Schedule H1 of the Drugs Rules, 1945, which necessitates sales only with a prescription from a registered medical practitioner and imposes stricter record-keeping requirements.

According to the ministry, "This amendment is anticipated to enhance regulatory oversight over medicinal products containing alcohol, ensuring they are supplied exclusively through regulated pharmaceutical channels.

It aims to significantly diminish the risk of diversion and misuse while maintaining their availability for legitimate therapeutic purposes."

The changes are designed to rectify the misuse of provisions under Schedule K that allowed certain products to bypass alcohol content limits.

Previously, this exemption permitted the sale of products with ethyl alcohol levels as high as 80%, despite being marketed as medicinal.

The proposed amendments aim to establish a consistent regulatory framework for all medicinal products containing ethyl alcohol.

Current regulations already set alcohol limits for various traditional medicine systems.

For instance, Rule 161 allows Ayurvedic, Siddha, and Unani syrups to contain up to 16% alcohol, while Rule 106B restricts alcohol content in Homeopathic medicines to 12%.

The amendment suggests that medicinal formulations with more than 12% ethyl alcohol should not be exempt under Schedule K simply because they include ingredients like cardamom or ginger.

This initiative is part of the government's ongoing efforts to enhance the regulatory framework for pharmaceuticals, promote responsible use of medicinal products, and protect public health.

A detailed gazette notification outlining these amendments is available on the ministry's website.